Selection of subjects for clinical trials in Alzheimer’s disease and mild cognitive impairment with machine learning analysis of MRI and CSF biomarkers

Por Escudero Javier, Zajicek John P, Ifeachor Emmanuel
Publicado em 2011-12-01

Selection of subjects for clinical trials in Alzheimer’s disease and mild cognitive impairment with machine learning analysis of MRI and CSF biomarkers

Por Escudero, Javier, Zajicek, John P, Ifeachor, Emmanuel
Publicado em 2011

Analysis and validation of a Parkinson’s disease register as a recruitment tool for clinical studies

Por Carroll, Camille B, Palmer, Amy, Cosby, Christine, Zajicek, John P
Publicado em 2011

A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer’s disease and Parkinson’s disease

Por McGhee, David J. M., Ritchie, Craig W., Zajicek, John P., Counsell, Carl E.
Publicado no BMC Neurol (2016)

Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characterist...

Por Wright Dave E, Creanor Siobhan, Vickery Jane, Ingram Wendy M, Zajicek John P, Hobart Jeremy C
Publicado em 2010-10-01

Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characterist...

Por Zajicek, John P, Ingram, Wendy M, Vickery, Jane, Creanor, Siobhan, Wright, Dave E, Hobart, Jeremy C
Publicado em 2010

Delta-9-tetrahydrocannabinol protects against MPP(+) toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis

Por Zeissler, Marie-Louise, Eastwood, Jordan, McCorry, Kieran, Hanemann, C. Oliver, Zajicek, John P., Carroll, Camille B.
Publicado no Oncotarget (2016)

A systematic review of biomarkers for disease progression in Parkinson’s disease

Por McGhee, David JM, Royle, Pamela L, Thompson, Paul A, Wright, David E, Zajicek, John P, Counsell, Carl E
Publicado em 2013

A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease

Por McGhee, David J. M., Ritchie, Craig W., Thompson, Paul A., Wright, David E., Zajicek, John P., Counsell, Carl E.
Publicado em 2014

Improving the quality of cognitive screening assessments: ACEmobile, an iPad-based version of the Addenbrooke's Cognitive Examination-III

Por Newman, Craig G.J., Bevins, Adam D., Zajicek, John P., Hodges, John R., Vuillermoz, Emil, Dickenson, Jennifer M., Kelly, Denise S., Brown, Simona, Noad, Rupert F.
Publicado no Alzheimers Dement (Amst) (2017)